Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

A new blood test may help detect liver cancer earlier in people with chronic liver disease, potentially improving access to ...

Liver cancer remains a significant global health challenge and can develop silently in patients who are unaware they have underlying liver disease. To discuss this unmet need in cancer care, CURE sat ...

A groundbreaking international trial has found that semaglutide, a drug best known for treating diabetes and obesity, can also reverse a dangerous liver disease called MASH in nearly two-thirds of ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease), including 65% of those with type 2 diabetes (T2D) ...

Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal approaches.

Lucknow: Hepatic venous pressure gradient (HVPG), special medical test to gauge pressure inside liver, was performed for the ...

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer. Dr. Anjana Pillai explains, in an interview with ...

Jan 23 (Reuters) - Bausch Health said on Friday its experimental treatment failed to prevent the first clinically visible symptoms of a neurological condition in patients with a type of liver disease, ...

News and commentary from the world of gastroenterology and hepatology ...